文献速递慢性肾脏病肾血管病与高血压

接受胰岛素的2型糖尿病患者尿白蛋白排泄与心血管结局及全因死亡率的关系

The relationship between urinary albumin excretion, cardiovascular outcomes and total mortality among a large cohort of insulin-treated patients with type 2 diabetes in routine primary care practices.
PubMed 文献 · Nephrol Dial Transplant · 2020-01-01

结果显示UACR升高与主要不良心血管事件复合终点风险独立相关,但UACR分类本身不能预测全因死亡风险。

要点

  • 起始胰岛素时UACR≥10 mg/g即与5年心血管事件复合终点风险增加相关。
  • UACR 10-29、30-300和>300 mg/g组复合终点风险分别较<10 mg/g组高9%、30%和98%。
  • UACR分类本身不能预测全因死亡风险。

核心结论

  • 在接受胰岛素治疗的2型糖尿病患者中,尿白蛋白肌酐比升高与主要不良心血管事件复合终点风险独立相关。
  • UACR分类本身不能预测全因死亡风险。

主要发现

  • 随访5年,以全因死亡、非致死性心肌梗死或卒中组成3点复合终点。
  • 与起始胰岛素时UACR<10 mg/g者相比,UACR 10-29、30-300和>300 mg/g者的复合终点调整风险分别高9%、30%和98%。
  • UACR分类本身不能预测全因死亡风险。

关键数值与推荐

  • UACR分类界值:<10、10-29、30-300和>300 mg/g。
  • 复合终点调整风险分别较<10 mg/g组高9%、30%和98%。

临床怎么用

  • 在接受胰岛素治疗的2型糖尿病患者中,应关注起始胰岛素时的UACR水平以评估心血管事件风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Albuminuria is a recognized diagnostic and prognostic marker of chronic kidney disease and cardiovascular (CV) risk but the well-known relationship between increments in urinary albumin:creatinine ratio (UACR) and CV outcomes and mortality has not been fully explored in insulin-treated patients with type 2 diabetes (T2D) in routine clinical care. METHODS: We investigated data for insulin users with T2D from UK general practices between 2007 and 2014. The UACR at the time of insulin initiation was measured and categorized as <10, 10- 29, 30-300 and >300 mg/g. Patients were followed up for 5 years or the earliest occurrence of all-cause mortality, non-fatal myocardial infarction or stroke. Cox proportional hazards models were fitted to estimate the risk of a composite of these events. RESULTS: A total of 12 725 patients with T2D (mean age 58.6 ± 13.8 years, mean haemoglobin A1c 8.7 ± 1.8%) initiating insulin therapy between 2007 and 2014 met the inclusion criteria. Compared with patients whose ACR levels at insulin initiation were <10 mg/g, the adjusted risk of the 3-point composite endpoint was 9, 30 and 98% higher in those with ACR levels between 10-29, 30-300 and >300 mg/g, respectively, after a follow-up period of 5 years. The ACR category on its own did not predict risk of all-cause mortality. CONCLUSIONS: This study shows that in patients with T2D on insulin therapy, increased urinary ACR is independently associated with an increased risk of major adverse CV events and all-cause mortality.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Anyanwagu U, Donnelly R, Idris I, et al. The relationship between urinary albumin excretion, cardiovascular outcomes and total mortality among a large cohort of insulin-treated patients with type 2 diabetes in routine primary care practices. Nephrol Dial Transplant. 2020. PMID: 30169825. doi:10.1093/ndt/gfy258

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。